Silo Pharma (SILO) Operating Expenses (2010 - 2026)

Silo Pharma has disclosed Operating Expenses across 14 years of filings, most recently posting $928949.0 for Q2 2026.

• In Q2 2026, Operating Expenses fell 26.57% year-over-year to $928949.0; the TTM figure through Jun 2026 stood at $4.5 million (down 14.88% YoY), while the FY2025 annual figure was $4.3 million, down 9.71% from the prior year.
• Operating Expenses came in at $928949.0 for Q2 2026 at Silo Pharma, down from $1.6 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.8 million in Q4 2024 to a low of $510851.0 in Q2 2022.
• Average Operating Expenses over 5 years is $1.1 million, with a median of $1.0 million recorded in 2024.
• Year-over-year, Operating Expenses jumped 121.5% in 2023 and sank 57.16% in 2025.
• Over 5 years, Operating Expenses stood at $1.7 million in 2022, then retreated by 29.47% to $1.2 million in 2023, then jumped by 55.04% to $1.8 million in 2024, then slumped by 57.16% to $783861.0 in 2025, then increased by 18.51% to $928949.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $928949.0 in Q2 2026, $1.6 million in Q1 2026, and $783861.0 in Q4 2025.